SCHEMBL7170230

SCHEMBL7170230

O=C1c2ccccc2C(=O)N1CC1=Nc2cc(F)ccc2OC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
PKM P14618 1/20 0.45
TSHR P16473 1/20 0.45
KMT2A Q03164 1/20 0.45
CASP3 P42574 1/20 0.42
MAPT P10636 3/20 0.40
RECQL P46063 1/20 0.40
GRM5 P41594 1/20 0.39
RAF1 P04049 3/20 0.39
BRAF P15056 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
POLB P06746 1/20 0.38
RPS6KA2 Q15349 1/20 0.37
HPGD P15428 1/20 0.37
NR3C2 P08235 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7168282 0.74 MAPT (0.46) SMN1; SMN2PKMKMT2AMAPTALDH1A1
SCHEMBL24244089 0.66 SMN1; SMN2 (0.41) SMN1; SMN2KMT2ACASP3MAPTALDH1A1
SCHEMBL26625800 0.66 ACHE (0.61) SMN1; SMN2CASP3GRM5KDM4EADRA1D
SCHEMBL18669187 0.66 ACHE (0.61) SMN1; SMN2CASP3GRM5KDM4EADRA1D
SCHEMBL18668918 0.66 CASP3 (0.54) SMN1; SMN2CASP3RECQLGRM5KDM4E
SCHEMBL2644044 0.64 CASP3 (0.87) CASP3ALDH1A1ADRA1DADRA1AADRA1B
SCHEMBL7170227 0.64 EGFR (0.46) SMN1; SMN2PKMTSHRKMT2ACASP3
SCHEMBL14719576 0.64 SMN1; SMN2 (0.46) SMN1; SMN2PKMTSHRKMT2ACASP3
SCHEMBL11618643 0.64 UBE2N (0.67) SMN1; SMN2PKMTSHRKMT2ACASP3
SCHEMBL2478397 0.64 P2RX7 (0.52) TSHRKMT2ACASP3MAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573377-B1 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors DAIICHI PHARMACEUTICALS CO., LTD. (JP) 2003-06-03 US disclosed
US-6552018-B1 As antitumor agents DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-22 US disclosed
CN-1320122-A Pyrazole derivatives and salts thereof DAIICHI SEIYAKU CO (JP) 2001-10-31 CN disclosed
EP-1103551-A1 PYRAZOLE DERIVATIVES AND SALTS THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-05-30 EP disclosed
US-6169086-B1 AN ANTITUMOR AGENT FOR TREATING TUMOR RESISTANT TO 5-FLUOROURACIL TYPE DRUGS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed